Search results

The Chair of ANSTO, The Hon Dr Annabelle Bennett, AC SC, announced today that Mr Shaun Jenkinson has been reappointed as the Chief Executive Officer of ANSTO.

Timetable and Teams links

An investment that will secure the long term sustainability of nuclear medicine supply in Australia.

ANSTO has contributed to research on a novel therapeutic option for combatting antimicrobial-resistant Gram-negative bacteria, known as superbugs.

New screening method developed to confirm if deuteration improves metabolic stability.

ANSTO expertise focused on understanding of reduced water levels at Thirlmere Lakes in three year collaborative project

Defence requirements push your technology, we can help. ANSTO is home to some of Australia’s most important landmark research infrastructure – more than $1.3bn of it.  Our unique capabilities are used by thousands of Australian researchers from industry and academia every year.

See details of previously published customer updates from our Health products team. 

Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.

Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.

ANSTO provides a list of journal, book, technical and conference publications associated with the Australian Centre for Neutron Scattering, and the Centre for Accelerator Science.

An international team led by ANSTO has been awarded a prestigious program grant from the Foundation for Australia-Japan Studies.

Timetable and Teams links

A new study by researchers from Curtin University using the infrared (IR) and X-ray fluorescence microscopy (XFM) beamlines at the Australian Synchrotron has provided a better understanding of the chemical and elemental composition of latent fingermarks.

Radiation testing of electronic components at ANTO could benefit the aviation industry, regulators and most importantly, passengers as solar radiation events increase.